Wockhardt makes breakthrough in pneumonia treatment with Nafithromycin WCK 4873
Wockhardt is proud to announce the successful completion of its pivotal Phase 3 pneumonia study involving the macrolide antibiotic Nafithromycin WCK 4873. This significant achievement ... Read More
Health crisis in China: Surge in respiratory illnesses triggers emergency response
China is grappling with a staggering surge in respiratory illnesses, prompting the National Health Commission to call for an urgent increase in the number of ... Read More
Panic grips China: Unprecedented spike in child respiratory cases – What’s hidden?
In an alarming development, China reports a significant surge in respiratory illnesses among children in the north, causing international concern. The World Health Organization (WHO), ... Read More
Is a new pandemic emerging in China? Alarming pneumonia outbreak in schools!
China is facing a new health emergency as a mysterious pneumonia outbreak, eerily reminiscent of the early COVID-19 crisis, sweeps through schools. Hospitals in Beijing ... Read More
GSK to acquire vaccine developer Affinivax in deal worth up to $3.3bn
GlaxoSmithKline (GSK) has agreed to acquire Affinivax, a Boston-based clinical-stage vaccine developer, in a deal worth up to $3.3 billion. The consideration includes an upfront ... Read More
RedHill Biopharma expands manufacturing capacity of Covid-19 drug candidate opaganib in US
RedHill Biopharma has forged partnerships with a couple of US-based manufacturers for large-scale manufacturing of opaganib, its Covid-19 drug candidate. The Israeli biopharma company said ... Read More
Covid-19 phase 3 trial of lenzilumab : Humanigen announces positive interim results
Humanigen said that lenzilumab has delivered a clinically meaningful impact on the recovery of patients hospitalized with Covid-19, as per the interim data of a ... Read More
Gilead Sciences announces Veklury EU approval for COVID-19 treatment
Veklury EU approval : Gilead Sciences said that Veklury (remdesivir) has been given conditional marketing authorization from the European Commission as a treatment for SARS-CoV-2 ... Read More
Gilead Covid-19 drug candidate remdesivir delivers desired results in phase 3 trial
Remdesivir clinical trial results : Gilead Sciences said that the phase 3 SIMPLE trial, which has been evaluating the Covid-19 drug candidate remdesivir for the ... Read More
Apollo Hospitals to use AI platform from Zebra Med for COVID-19 detection
Zebra Medical Vision (Zebra-Med), an Israel-based deep-learning medical imaging analytics company, said that its software will be deployed by India's Apollo Hospitals Group to help ... Read More